Such a viewpoint is certain to disappoint the statin drugmakers, which sponsored the latest studies. "This train of CRP has so much momentum," Lloyd-Jones adds. "But if we look at it closely, it's not what it's cracked up to be."
Subscription Center
Is an inflammation protein the next cholesterol?
Such a viewpoint is certain to disappoint the statin drugmakers, which sponsored the latest studies. "This train of CRP has so much momentum," Lloyd-Jones adds. "But if we look at it closely, it's not what it's cracked up to be."
Diane Martindale is based in Toronto.
See what we're tweeting about
Deadline: Jul 15 2013
Reward: $5,000 USD
SciBX: Science-Business eXchange, a joint publication from the makers
Deadline: Aug 31 2013
Reward: $100,000 USD
The Geoffrey Beene Foundation Alzheimer’s Initiative (GBFAI) is launching the 2013 Geoffrey Beene Global NeuroDiscovery Challenge whose
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
Comments
Add Comment